Antibody and plasmablast response to 13-valent pneumococcal conjugate vaccine in chronic lymphocytic leukemia patients--preliminary report.

Antibody and plasmablast response to 13-valent pneumococcal conjugate vaccine in chronic lymphocytic leukemia patients--preliminary report.

Item
http://www.wikidata.org/entity/Q34704085
Vaccination in patients with primary immune deficiency, secondary immune deficiency and autoimmunity with immune regulatory abnormalitiesInfluenza and Pneumococcal Vaccination in Hematological Malignancies: a Systematic Review of Efficacy, Effectiveness, and SafetyChallenges in the Role of Gammaglobulin Replacement Therapy and Vaccination Strategies for Hematological MalignancyMonoclonal B-cell lymphocytosis and early-stage chronic lymphocytic leukemia: diagnosis, natural history, and risk stratificationPrognostic impact of Epstein-Barr virus (EBV)-DNA copy number at diagnosis in chronic lymphocytic leukemia.A review of supportive care and recommended preventive approaches for patients with chronic lymphocytic leukemia.Secondary immunodeficiency in lymphoproliferative malignancies.Bacterial Pneumonia in Patients with Cancer: Novel Risk Factors and Management.Host virus and pneumococcus-specific immune responses in high-count monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia: implications for disease progression.Pneumococcal vaccination in autoimmune rheumatic diseases.Trends in invasive pneumococcal disease (IPD) in cancer patients after the introduction of 7-valent pneumococcal conjugate vaccine (PCV7): A 20-year longitudinal study at a major urban cancer center.Antibodies against Pneumococcal Capsular Polysaccharides and Natural Anti-Galactosyl (Alpha-Gal) in Patients with Humoral Immunodeficiencies.Lack of adequate pneumococcal vaccination response in chronic lymphocytic leukaemia patients receiving ibrutinib.Effectiveness and practical uses of 23-valent pneumococcal polysaccharide vaccine in healthy and special populations.Antibody persistence after pneumococcal conjugate vaccination in patients with chronic lymphocytic leukemia.Anti-infective vaccination strategies in patients with hematologic malignancies or solid tumors-Guideline of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO).
P2860

Antibody and plasmablast response to 13-valent pneumococcal conjugate vaccine in chronic lymphocytic leukemia patients--preliminary report.

Item
http://www.wikidata.org/entity/Q34704085
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Antibody and plasmablast respo ...... patients--preliminary report.
@ast
Antibody and plasmablast respo ...... patients--preliminary report.
@en
Antibody and plasmablast respo ...... patients--preliminary report.
@nl
type
label
Antibody and plasmablast respo ...... patients--preliminary report.
@ast
Antibody and plasmablast respo ...... patients--preliminary report.
@en
Antibody and plasmablast respo ...... patients--preliminary report.
@nl
prefLabel
Antibody and plasmablast respo ...... patients--preliminary report.
@ast
Antibody and plasmablast respo ...... patients--preliminary report.
@en
Antibody and plasmablast respo ...... patients--preliminary report.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Antibody and plasmablast respo ...... a patients--preliminary report
@en
P2093
P2860
P304
P31
P356
10.1371/JOURNAL.PONE.0114966
P407
P433
P478
P50
P577
P5875
P698
P921
P932